Literature DB >> 33230024

Use of subcutaneous ketamine to rapidly improve severe treatment-resistant depression in a patient with Alzheimer's disease.

Fabio Lopes Rocha1, Ulisses Gabriel de Vasconcelos Cunha1, Roberta Campos Paschoalin1, Cláudia Hara2, Débora Pereira Thomaz1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33230024     DOI: 10.1097/YIC.0000000000000334

Source DB:  PubMed          Journal:  Int Clin Psychopharmacol        ISSN: 0268-1315            Impact factor:   1.659


× No keyword cloud information.
  1 in total

Review 1.  The Possible Application of Ketamine in the Treatment of Depression in Alzheimer's Disease.

Authors:  Islam Mohammad Shehata; Waniyah Masood; Nouran Nemr; Alexandra Anderson; Kamal Bhusal; Amber N Edinoff; Elyse M Cornett; Adam M Kaye; Alan D Kaye
Journal:  Neurol Int       Date:  2022-03-22
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.